| Literature DB >> 30916013 |
Abstract
This review offers a perspective on the future of paediatric sedation. This future will require continued evaluation of adverse events, their risk factors, and predictors. As the introduction of new sedatives with paediatric applications will remain limited, the potential role of mainstay sedatives administered by new routes, for new indications, and with new delivery techniques, should be considered. The role of non-pharmacological strategies for anxiolysis, along with the application of non-mainstay physiologic monitoring, may aid in the improvement of targeted sedation delivery. Understanding the mechanism and location of action of the different sedatives will remain an important focus. Important developments in paediatric sedation will require that large scale studies with global data contribution be conducted in order to support changes in sedation practice, improve the patient experience, and make sedation safer.Entities:
Keywords: ADV6209; anaesthesia; anxiolysis; ketamine; midazolam; monitoring; patient safety; sedation
Mesh:
Substances:
Year: 2019 PMID: 30916013 DOI: 10.1016/j.bja.2019.01.025
Source DB: PubMed Journal: Br J Anaesth ISSN: 0007-0912 Impact factor: 9.166